A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma
To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have superiority over the use of single biomarkers...
Main Authors: | Fa-Min Zeng, Jian-Zhong He, Shao-Hong Wang, De-kai Liu, Xiu-E. Xu, Jian-Yi Wu, En-Min Li, Li-Yan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/9828637 |
Similar Items
-
A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
by: Hui-Hui Cao, et al.
Published: (2014-01-01) -
A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma
by: Liu Peng, et al.
Published: (2019-01-01) -
High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.
by: Jian-Hua Wang, et al.
Published: (2012-01-01) -
A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma.
by: Li Shang, et al.
Published: (2014-01-01) -
Esophageal squamous cell carcinoma and prognosis in Taiwan
by: Ya‐Fu Cheng, et al.
Published: (2018-09-01)